Thyrotoxic periodic paralysis induced by pulse methylprednisolone

Internal Medicine

Volumn 46, Issue 17, 2007, Pages 1431-1434

  Wongraoprasert, Somporn ^a   Buranasupkajorn, Patinut ^a   Sridama, Vitaya ^a   Snabboon, Thiti ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Hypokalemia; Steroid; Thyroid periodic paralysis

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN; LIOTHYRONINE; METHYLPREDNISOLONE; POTASSIUM; PROPRANOLOL; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN; THYROXINE; GLUCOCORTICOID;

ADULT; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; BREATHING RATE; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DRUG MEGADOSE; EUTHYROIDISM; FATIGUE; FLACCID PARALYSIS; GRAVES DISEASE; HEART RIGHT BUNDLE BRANCH BLOCK; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; HYPOPHOSPHATEMIA; MALE; MUSCLE STRENGTH; MYALGIA; PERIODIC PARALYSIS; POTASSIUM BLOOD LEVEL; PULSE RATE; QT PROLONGATION; SYMPTOM; T WAVE; TENDON REFLEX; THYROTOXIC PERIODIC PARALYSIS; CHEMICALLY INDUCED DISORDER; DRUG PULSE THERAPY; HYPOKALEMIC PERIODIC PARALYSIS; POLYNEUROPATHY; THYROTOXICOSIS;

ADULT; GLUCOCORTICOIDS; GRAVES DISEASE; HUMANS; HYPOKALEMIC PERIODIC PARALYSIS; MALE; METHYLPREDNISOLONE; POLYNEUROPATHIES; PULSE THERAPY, DRUG; THYROTOXICOSIS;

EID: 34548721579     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0044     Document Type: Article

References (10)

1. Kung AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 91: 2490-2495, 2006.
2. Manoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 159: 601-606, 1999.
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245, 1981.
4. Miyashita Y, Monden T, Yamamoto K, et al. Ventricular fibrillation due to severe hypokalemia induced by steroid treatment in a patient with thyrotoxic periodic paralysis. Intern Med 45: 11-13, 2006.
5. Liu Z, Braverman LE, Malabanan A. Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone. Endocr Pract 12: 427-431, 2006.
6. Celsi G, Nishi A, Akusjarvi G, et al. Abundance of Na(+)-K(+)-ATPase mRNA is regulated by glucocorticoid hormones in infant rat kidneys. Am J Physiol 260: F192-F197, 1991.
7. Ludvik B, Clodi M, Kautzky-Willer A, et al. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Diabetologia, 36: 84-87, 1993.
8. Quinkler M, Stewart PM. Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab 88: 2384-2392, 2003.
9. Owczarek J, Jasinska M, Orszulak-Michalak D. Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep 57: 23-34, 2005.
10. Tassone H, Moulin A, Henderson SO. The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. J Emerg Med 26: 157-161, 2004.